Novo Nordisk, National Center for Drug Screening, World Health Organization infectious news

Novo Nordisk donated a license to its small molecule compound library to the National Center for Drug Screening. The center will use both the actual compounds and an associated database for screening activities to identify new compounds for infectious tropical diseases. WHO's Special Program for Research and Training in Tropical Diseases (TDR) will select targets and screens. ...